LaBranche & Co. Inc. (NYSE: LAB) has been rumored to be making a serious change or sale for some time. Tonight, that was partially confirmed. The company has signed a ... Read Full Story »
These are some of the top pre-market analyst downgrades and negative calls we have seen on Wall Street this morning:Avon Products (AVP) Cut to Neutral at Goldman Sachs.Cardinal Health (CAH) ... Read Full Story »
These are some of the early bird upgrades and positive research calls we have seen from Wall Street analysts this Wednesday morning with more than two hours to the open:AU ... Read Full Story »
Goldman Sachs has lowered estimates on many financial services players this morning:AllianceBernstein (AB) (buy);AMBAC Financial (ABK) (neutral);Blackrock (BLK) (buy);Calamos Asset Mgmt. (CLMS) (neutral);CME Group (CME) (buy);Franklin Resources (BEN) (neutral); Gamco ... Read Full Story »
We have already noted the Van der Moolen (NYSE:VDM) exit of all NYSE Specialist activities and we've already covered some of the other key stocks where Van der Moolen acts ... Read Full Story »
Labranche (LAB) Being a specialist firm trading stocks has gotten to be nasty business. Shares drop to $4.65 from 52-week high of $12.21.King Pharmaceuticals (KG) Still taking hammer because patent ... Read Full Story »